Ocera Therapeutics Inc. (NASDAQ:OCRX) shares shot up 10.2% on Friday . The stock traded as high as $2.42 and last traded at $2.26, with a volume of 58,725 shares. The stock had previously closed at $2.05.

Separately, Zacks Investment Research lowered shares of Ocera Therapeutics from a “buy” rating to a “hold” rating in a report on Thursday, July 7th.

The firm’s market capitalization is $49.82 million. The stock has a 50 day moving average price of $2.51 and a 200-day moving average price of $2.69.

Ocera Therapeutics (NASDAQ:OCRX) last released its earnings results on Wednesday, August 3rd. The biopharmaceutical company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.02. On average, analysts expect that Ocera Therapeutics Inc. will post ($1.34) earnings per share for the current year.

Ocera Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company is focused on acute and chronic orphan liver diseases. The Company is focused on the development and commercialization of its clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine phenylacetate, which functions as an ammonia scavenger.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.